Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

A cleanroom sleeping environment's impact on markers of oxidative stress, immune dysregulation, and behavior in children with autism spectrum disorders.

Faber S, Zinn GM, Boggess A, Fahrenholz T, Kern JC 2nd, Kingston HM.

BMC Complement Altern Med. 2015 Mar 19;15:71. doi: 10.1186/s12906-015-0564-0.

2.

Redox metabolism abnormalities in autistic children associated with mitochondrial disease.

Frye RE, Delatorre R, Taylor H, Slattery J, Melnyk S, Chowdhury N, James SJ.

Transl Psychiatry. 2013 Jun 18;3:e273. doi: 10.1038/tp.2013.51.

3.
4.

Cysteinyl leukotriene correlated with 8-isoprostane levels as predictive biomarkers for sensory dysfunction in autism.

Qasem H, Al-Ayadhi L, El-Ansary A.

Lipids Health Dis. 2016 Aug 17;15:130. doi: 10.1186/s12944-016-0298-0.

5.
6.
7.

Pilot study of the effect of methyl B12 treatment on behavioral and biomarker measures in children with autism.

Bertoglio K, Jill James S, Deprey L, Brule N, Hendren RL.

J Altern Complement Med. 2010 May;16(5):555-60. doi: 10.1089/acm.2009.0177.

PMID:
20804367
8.

Effect of a vitamin/mineral supplement on children and adults with autism.

Adams JB, Audhya T, McDonough-Means S, Rubin RA, Quig D, Geis E, Gehn E, Loresto M, Mitchell J, Atwood S, Barnhouse S, Lee W.

BMC Pediatr. 2011 Dec 12;11:111. doi: 10.1186/1471-2431-11-111.

9.

The relationship between sleep problems and daytime behavior in children of different ages with autism spectrum disorders.

Sikora DM, Johnson K, Clemons T, Katz T.

Pediatrics. 2012 Nov;130 Suppl 2:S83-90. doi: 10.1542/peds.2012-0900F.

PMID:
23118258
10.

Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism.

King BH, Hollander E, Sikich L, McCracken JT, Scahill L, Bregman JD, Donnelly CL, Anagnostou E, Dukes K, Sullivan L, Hirtz D, Wagner A, Ritz L; STAART Psychopharmacology Network.

Arch Gen Psychiatry. 2009 Jun;66(6):583-90. doi: 10.1001/archgenpsychiatry.2009.30.

12.

Feasibility of exposure response prevention to treat repetitive behaviors of children with autism and an intellectual disability: a brief report.

Boyd BA, Woodard CR, Bodfish JW.

Autism. 2013 Mar;17(2):196-204. doi: 10.1177/1362361311414066. Epub 2011 Oct 5.

13.

Abnormal transsulfuration metabolism and reduced antioxidant capacity in Chinese children with autism spectrum disorders.

Han Y, Xi QQ, Dai W, Yang SH, Gao L, Su YY, Zhang X.

Int J Dev Neurosci. 2015 Nov;46:27-32. doi: 10.1016/j.ijdevneu.2015.06.006. Epub 2015 Jul 3.

PMID:
26150135
14.

Urinary oxidative stress markers in children with autism.

Damodaran LP, Arumugam G.

Redox Rep. 2011;16(5):216-22. doi: 10.1179/1351000211Y.0000000012.

PMID:
22005342
15.

Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes.

Ashwood P, Enstrom A, Krakowiak P, Hertz-Picciotto I, Hansen RL, Croen LA, Ozonoff S, Pessah IN, Van de Water J.

J Neuroimmunol. 2008 Nov 15;204(1-2):149-53. doi: 10.1016/j.jneuroim.2008.07.006.

16.

Childhood autism spectrum disorders with and without epilepsy: clinical implications.

Shubrata KS, Sinha S, Seshadri SP, Girimaji S, Subbakrishna DK, Srinath S.

J Child Neurol. 2015 Mar;30(4):476-82. doi: 10.1177/0883073814540521. Epub 2014 Jul 17.

PMID:
25038126
17.

Parental report of sleep problems in children with autism.

Schreck KA, Mulick JA.

J Autism Dev Disord. 2000 Apr;30(2):127-35.

PMID:
10832777
18.

Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial.

Rossignol DA, Rossignol LW, Smith S, Schneider C, Logerquist S, Usman A, Neubrander J, Madren EM, Hintz G, Grushkin B, Mumper EA.

BMC Pediatr. 2009 Mar 13;9:21. doi: 10.1186/1471-2431-9-21. Erratum in: BMC Pediatr. 2012 Dec;42(4):236.

19.

Transcutaneous electrical acupoint stimulation in children with autism and its impact on plasma levels of arginine-vasopressin and oxytocin: a prospective single-blinded controlled study.

Zhang R, Jia MX, Zhang JS, Xu XJ, Shou XJ, Zhang XT, Li L, Li N, Han SP, Han JS.

Res Dev Disabil. 2012 Jul-Aug;33(4):1136-46. doi: 10.1016/j.ridd.2012.02.001. Epub 2012 Mar 22.

PMID:
22502839
20.

The Coping Cat program for children with anxiety and autism spectrum disorder: a pilot randomized controlled trial.

McNally Keehn RH, Lincoln AJ, Brown MZ, Chavira DA.

J Autism Dev Disord. 2013 Jan;43(1):57-67. doi: 10.1007/s10803-012-1541-9.

Supplemental Content

Support Center